Tecan Group AG (SWX: TECN)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 3.61B |
| Revenue (ttm) | 1.00B |
| Net Income (ttm) | 101.34M |
| Shares Out | 12.82M |
| EPS (ttm) | 7.89 |
| PE Ratio | 35.65 |
| Forward PE | 29.48 |
| Dividend | 3.00 (1.07%) |
| Ex-Dividend Date | Apr 22, 2024 |
| Volume | 17,014 |
| Open | 282.40 |
| Previous Close | 282.40 |
| Day's Range | 280.60 - 286.40 |
| 52-Week Range | 251.00 - 392.00 |
| Beta | 0.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 12, 2025 |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The compa... [Read more]
Financial Performance
In 2023, Galenica AG's revenue was 3.76 billion, an increase of 4.47% compared to the previous year's 3.60 billion. Earnings were 285.37 million, an increase of 72.81%.
News
Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript
Tecan Group AG (OTCPK:TCHBF) Q2 2024 Earnings Conference Call August 13, 2024 2:30 AM ETCompany ParticipantsMartin Brandle - IRAchim Leoprechting - CEOTania...
Tecan Shares Slump Most in Two Decades After Warning on Outlook
Tecan Group AG shares slumped the most in two decades after the Swiss maker of laboratory equipment cut its guidance for the year, citing reduced spending by pharmaceutical companies and a plunge in s...